FDA Drug recall D-0060-2025
Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01
- FDA Drug
- Class II
- ongoing
- Published 2024-11-27
On 2024-11-27 the FDA classified a Class II recall of Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01 by Safecor Health, citing cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0060-2025 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2024-11-11 |
| Published | 2024-11-27 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Safecor Health |
| Distribution | US |
Product
Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01
Reason
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Identifiers
| code_info | Lot# 34A0054, exp. date 05/07/2026 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0060-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.